ACHV stock forecast
Our latest prediction for Achieve Life Sciences, Inc.'s stock price was made on the May 23, 2019 when the stock price was at 3.63$.
In the short term (2weeks), ACHV's stock price should outperform the market by 6.26%. During that period the price should oscillate between -9.35% and +17.42%.
In the medium term (3months), ACHV's stock price should outperform the market by 1.46%. During that period the price should oscillate between -22.69% and +43.63%.Get email alerts
Create a solid portfolio with ACHV
About Achieve Life Sciences, Inc.
Achieve Life Sciences, Inc. is a clinical-stage pharmaceutical company, which engages in the development and commercialization of cytisinicline for smoking cessation. Its products includes cytisine, a plant-based alkaloid with a binding affinity to the nicotinic acetylcholine receptor. The company was founded in October 1991 and is headquartered in Vancouver, Canada.
At the moment the company doesn't generate any revenue.
On its last earning announcement, the company reported a loss of -2.06$ per share.
The book value per share is 3.61$
Three months stock forecastMay 23, 2019
|Revenue USD||Gross Margin||Operating Income||Operating Margin||Net Income||Earnings Per Share||Dividends||Payout Ratio||Shares||Book Value Per Share||Operating Cash Flow||Cap Spending||Free Cash Flow|